Royal Bank of Canada Increases Position in Azenta, Inc. (NASDAQ:AZTA)

Royal Bank of Canada boosted its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 9.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 573,443 shares of the company's stock after acquiring an additional 47,936 shares during the quarter. Royal Bank of Canada owned about 1.25% of Azenta worth $28,673,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Picton Mahoney Asset Management lifted its position in Azenta by 305.7% during the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after acquiring an additional 532 shares during the period. Headlands Technologies LLC acquired a new position in shares of Azenta in the 4th quarter valued at about $40,000. Covestor Ltd lifted its holdings in shares of Azenta by 64.2% in the 4th quarter. Covestor Ltd now owns 2,043 shares of the company's stock valued at $102,000 after buying an additional 799 shares during the period. KBC Group NV lifted its holdings in shares of Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares during the period. Finally, Quarry LP acquired a new position in shares of Azenta in the 4th quarter valued at about $110,000. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Stock Up 0.0%

Shares of AZTA stock traded up $0.01 on Thursday, hitting $27.11. The company had a trading volume of 233,610 shares, compared to its average volume of 691,432. Azenta, Inc. has a twelve month low of $23.91 and a twelve month high of $63.58. The company has a 50-day moving average price of $28.44 and a 200-day moving average price of $40.63. The firm has a market cap of $1.24 billion, a P/E ratio of -9.09 and a beta of 1.64.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. During the same period in the previous year, the business posted $0.06 earnings per share. The business's revenue was up 5.1% compared to the same quarter last year. Equities research analysts expect that Azenta, Inc. will post 0.53 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on AZTA shares. TD Cowen raised Azenta to a "hold" rating in a report on Thursday, February 27th. Evercore ISI boosted their price objective on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Finally, Needham & Company LLC decreased their price objective on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.